Longevixx Tirzepatide Review: $299/Month, No Pharmacy Named (2026)

Longevixx charges $299 a month for compounded tirzepatide, month to month, and the Terms fix the cycle at every 30 days until you cancel. That figure is one standing rate with no introductory rung beneath it: the checkout card shows no struck anchor and no first-month discount, which is rarer than it sounds. It was read on 1 September 2026 on the treatment menu that opens once the eligibility questionnaire is finished.¹

The price is clean, and the one beneath it is not

The semaglutide line is where the care is needed. The homepage advertises "GLP-1 weight loss from $149/mo", and the menu shows $149 against a struck $199 with no explanation attached. Only the checkout screen labels it — "$50 off first month". The standing semaglutide rate is $199 a month, so the public floor is a floor on an introductory price. Tirzepatide is not marketed that way, and the difference matters.

Who fills the prescription is not on the site

Longevixx publishes a named legal entity, Longevixx LLC, with a street address in Charlotte, North Carolina, a phone number and stated clinical hours. It does not publish a pharmacy. A census across every page and all 25 intake screens found no compounding pharmacy, no medical group, no clinician name and no NPI anywhere on the domain, and the words 503A and 503B appear nowhere. The footer describes "state-licensed compounding pharmacies" as a class, and the Terms collect a pharmacy and a medical-group share of your payment without naming either.

Four promises the paperwork does not carry

There is no refund policy page and no general refund right; the only refund sentence in the Terms covers a pricing error the company itself makes. The checkout promises "24/7 access to our care team and licensed clinicians", while the contact page publishes clinical hours of Monday to Friday, 9:00 AM to 5:00 PM. A "$0 if you're not approved" line runs on the homepage with no matching clause anywhere in the Terms. And "Telehealth in 50 states" sits against a contact page saying the service operates where it is licensed, with no exclusion list published.

The brand-vs-compounded question

This is compounded tirzepatide, not Zepbound. A compounded preparation is made by a pharmacy, is not an FDA-approved finished product, and was not the drug the pivotal trials studied. Our guide to whether compounded tirzepatide is still legal in 2026 explains where that leaves a buyer today.

How the care model holds up

The good part is real, and worth stating plainly: nothing is hidden behind an account, the questionnaire is the only gate, the price does not move at renewal, and the included list runs to physician review, care coaching and a dietitian visit at no separate charge. The weak part is that you are asked for $299 a month by a company that will not tell you which pharmacy compounds the vial or which clinician signs the prescription. At that price, on this evidence, the disclosure is thin.

Does the drug work? (Separate from the provider)

Grade the seller on price, disclosure and oversight, and grade the molecule on its trials. Tirzepatide's are strong — around 15% to 21% of body weight over 72 weeks in SURMOUNT-1², and better than semaglutide when the two met directly in SURMOUNT-5³ — though both were run on the branded product at approved doses. The tirzepatide evidence guide has the detail.

The honest verdict

Longevixx sells an honest price attached to an anonymous supply chain, and $299 is a lot to pay for that trade. Magnolia Regenerative Medicine charges $199 a month and names no pharmacy either, but at least publishes two clinic addresses you could drive to. Mondae is $126 per 28-day cycle, less than half the money, though its billing runs thirteen charges a year rather than twelve. See the ranked best tirzepatide providers list for where all three land.